IS7200A - Notkun á írbesartan til framleiðslu á lækningalyfjum sem notuð eru til að koma í veg fyrir eða meðhöndla lungnaháþrýsting - Google Patents

Notkun á írbesartan til framleiðslu á lækningalyfjum sem notuð eru til að koma í veg fyrir eða meðhöndla lungnaháþrýsting

Info

Publication number: IS7200A
Authority: IS; Iceland
Prior art keywords: irbesartan; manufacture; prevent; medicinal products; pulmonary hypertension
Prior art date: 2001-10-26

Application number

IS7200A

Other languages

English (en)

Other versions

IS2849B (is

Inventor

Cosnier-Pucheu Sylvie

Nisato Dino

Roccon Alain

Original Assignee

Sanofi-Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-26

Filing date

2004-03-29

Publication date

2004-03-29

2004-03-29 Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis

2004-03-29 Publication of IS7200A publication Critical patent/IS7200A/is

2013-09-15 Publication of IS2849B publication Critical patent/IS2849B/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)

IS7200A 2001-10-26 2004-03-29 Notkun á írbesartani til framleiðslunnar á lyfjum sem eru notuð til að fyrirbyggja eða meðhöndla lungnaháþrýsting IS2849B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0113936A FR2831446B1 (fr)	2001-10-26	2001-10-26	Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire
PCT/FR2002/003439 WO2003035062A1 (fr)	2001-10-26	2002-10-09	Utilisation de l'irbesartan pour la preparation de medicaments utiles pour la prevention ou le traitement de l'hypertension pulmonaire

Publications (2)

Publication Number	Publication Date
IS7200A true IS7200A (is)	2004-03-29
IS2849B IS2849B (is)	2013-09-15

Family

ID=8868812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7200A IS2849B (is)	2001-10-26	2004-03-29	Notkun á írbesartani til framleiðslunnar á lyfjum sem eru notuð til að fyrirbyggja eða meðhöndla lungnaháþrýsting

Country Status (24)

Country	Link
US (2)	US20040242567A1 (is)
EP (1)	EP1441723B1 (is)
JP (1)	JP4542777B2 (is)
CN (1)	CN100418526C (is)
AT (1)	ATE361071T1 (is)
AU (1)	AU2002350832B2 (is)
BR (1)	BR0213479A (is)
CA (1)	CA2461625C (is)
CY (1)	CY1106746T1 (is)
DE (1)	DE60219940T2 (is)
DK (1)	DK1441723T3 (is)
EA (1)	EA007952B1 (is)
ES (1)	ES2286304T3 (is)
FR (1)	FR2831446B1 (is)
HU (1)	HUP0401633A3 (is)
IL (2)	IL161116A0 (is)
IS (1)	IS2849B (is)
MX (1)	MXPA04003910A (is)
NO (1)	NO332313B1 (is)
NZ (1)	NZ532130A (is)
PL (1)	PL209263B1 (is)
PT (1)	PT1441723E (is)
WO (1)	WO2003035062A1 (is)
ZA (1)	ZA200402696B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8912174B2 (en)	2003-04-16	2014-12-16	Mylan Pharmaceuticals Inc.	Formulations and methods for treating rhinosinusitis
US9808471B2 (en)	2003-04-16	2017-11-07	Mylan Specialty Lp	Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en)	2003-04-16	2010-10-12	Dey, L.P.	Nasal pharmaceutical formulations and methods of using the same
US20040265238A1 (en) *	2003-06-27	2004-12-30	Imtiaz Chaudry	Inhalable formulations for treating pulmonary hypertension and methods of using same
TR200301553A1 (tr) *	2003-09-18	2005-10-21	Nobel �La� Sanay�� Ve T�Caret A.�.	İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar
US8226977B2 (en)	2004-06-04	2012-07-24	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing irbesartan
WO2006067601A1 (en) *	2004-12-23	2006-06-29	Ranbaxy Laboratories Limited	Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation
CN100367959C (zh) *	2006-08-29	2008-02-13	陈俊云	一种含有依贝沙坦的药物
GB0617171D0 (en) *	2006-08-31	2006-10-11	Generics Uk Ltd	Novel compositions and methods
AU2022244585A1 (en) *	2021-03-23	2023-09-21	Dimerix Bioscience Pty Ltd	Treatment of inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5258510A (en) *	1989-10-20	1993-11-02	Otsuka Pharma Co Ltd	Benzoheterocyclic compounds
US5270317A (en) *	1990-03-20	1993-12-14	Elf Sanofi	N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
TW201738B (is) *	1990-03-20	1993-03-11	Sanofi Co
RU2086544C1 (ru) *	1991-06-13	1997-08-10	Хоффманн-Ля Рош АГ	Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
US5292741A (en) *	1992-08-18	1994-03-08	Merck & Co., Inc.	Macrocycles incorporating quinazolinones
EP1106210A3 (en)	1999-12-07	2003-12-03	Pfizer Products Inc.	Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications

2001
- 2001-10-26 FR FR0113936A patent/FR2831446B1/fr not_active Expired - Fee Related
2002
- 2002-10-09 ES ES02785535T patent/ES2286304T3/es not_active Expired - Lifetime
- 2002-10-09 CN CNB028213041A patent/CN100418526C/zh not_active Expired - Fee Related
- 2002-10-09 IL IL16111602A patent/IL161116A0/xx unknown
- 2002-10-09 HU HU0401633A patent/HUP0401633A3/hu unknown
- 2002-10-09 EA EA200400438A patent/EA007952B1/ru not_active IP Right Cessation
- 2002-10-09 MX MXPA04003910A patent/MXPA04003910A/es active IP Right Grant
- 2002-10-09 DE DE60219940T patent/DE60219940T2/de not_active Expired - Lifetime
- 2002-10-09 PL PL368737A patent/PL209263B1/pl unknown
- 2002-10-09 JP JP2003537629A patent/JP4542777B2/ja not_active Expired - Fee Related
- 2002-10-09 AU AU2002350832A patent/AU2002350832B2/en not_active Ceased
- 2002-10-09 NZ NZ532130A patent/NZ532130A/en not_active IP Right Cessation
- 2002-10-09 DK DK02785535T patent/DK1441723T3/da active
- 2002-10-09 US US10/492,804 patent/US20040242567A1/en not_active Abandoned
- 2002-10-09 CA CA2461625A patent/CA2461625C/en not_active Expired - Fee Related
- 2002-10-09 PT PT02785535T patent/PT1441723E/pt unknown
- 2002-10-09 WO PCT/FR2002/003439 patent/WO2003035062A1/fr not_active Ceased
- 2002-10-09 BR BR0213479-9A patent/BR0213479A/pt not_active Application Discontinuation
- 2002-10-09 EP EP02785535A patent/EP1441723B1/fr not_active Expired - Lifetime
- 2002-10-09 AT AT02785535T patent/ATE361071T1/de active
2004
- 2004-03-25 IL IL161116A patent/IL161116A/en not_active IP Right Cessation
- 2004-03-29 IS IS7200A patent/IS2849B/is unknown
- 2004-04-06 ZA ZA2004/02696A patent/ZA200402696B/en unknown
- 2004-04-23 NO NO20041732A patent/NO332313B1/no not_active IP Right Cessation
2007
- 2007-07-19 CY CY20071100964T patent/CY1106746T1/el unknown
2009
- 2009-06-03 US US12/477,562 patent/US8088827B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
MXPA04003910A (es)	2004-07-23
US8088827B2 (en)	2012-01-03
EP1441723A1 (fr)	2004-08-04
IL161116A (en)	2010-12-30
US20040242567A1 (en)	2004-12-02
IL161116A0 (en)	2004-08-31
PT1441723E (pt)	2007-07-26
WO2003035062A1 (fr)	2003-05-01
ES2286304T3 (es)	2007-12-01
ATE361071T1 (de)	2007-05-15
NZ532130A (en)	2006-10-27
DE60219940T2 (de)	2008-01-17
JP4542777B2 (ja)	2010-09-15
IS2849B (is)	2013-09-15
CA2461625A1 (en)	2003-05-01
NO20041732L (no)	2004-07-23
EP1441723B1 (fr)	2007-05-02
NO332313B1 (no)	2012-08-27
HUP0401633A2 (hu)	2004-12-28
CN1610548A (zh)	2005-04-27
HUP0401633A3 (en)	2009-06-29
CN100418526C (zh)	2008-09-17
EA007952B1 (ru)	2007-02-27
PL368737A1 (en)	2005-04-04
CY1106746T1 (el)	2012-05-23
ZA200402696B (en)	2005-06-29
BR0213479A (pt)	2004-11-03
JP2005506369A (ja)	2005-03-03
FR2831446B1 (fr)	2004-03-05
AU2002350832B2 (en)	2006-11-30
DE60219940D1 (de)	2007-06-14
PL209263B1 (pl)	2011-08-31
DK1441723T3 (da)	2007-09-10
EA200400438A1 (ru)	2004-10-28
FR2831446A1 (fr)	2003-05-02
US20090247510A1 (en)	2009-10-01
CA2461625C (en)	2011-07-05

Publication	Publication Date	Title
NL300933I2 (nl)	2018-04-26	Letermovir
NO20055863L (no)	2001-09-12	W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO20071343L (no)	2007-05-30	Substituerte fenylaminotiazoler og anvendelse derav
BG66084B1 (bg)	2011-03-31	Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
NO20071078L (no)	2007-04-26	Antivirale forbindelser
NO20070866L (no)	2007-04-13	Antivirale forbindelser.
TNSN05045A1 (en)	2007-05-14	Indole or benzimidazole derivatives for modulating ikappab kinase
DK1456212T3 (da)	2007-04-02	6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
NO20050091L (no)	2005-04-06	Fremgangsmater for fremstilling av fibrinogen
DE60141636D1 (de)	2010-05-06	Phospholipidderivate von valproinsäure und ihre kombinationen
MY141528A (en)	2010-05-14	Anilinopyrazole derivatives useful for the treatment of diabetes
CY1106746T1 (el)	2012-05-23	Χρηση του irbesartan για την προληψη ή τη θεραπεια της πνευμονικης υπερτασης
DE60329326D1 (de)	2009-10-29	Tace inhibitoren
NO20055612L (no)	2006-01-20	Anti-inflammatoriske fosfonatforbindelser
ATE410235T1 (de)	2008-10-15	Behandlung von ballastwasser
DK1843771T3 (da)	2012-01-16	Anvendelse af pyrimidylaminobenzamider til behandling af sygdomme, der responderer på modulation af Tie-2-kinase-aktiviteten
AR046245A1 (es)	2005-11-30	Sales de calcio de rabeprazol
DE60326348D1 (de)	2009-04-09	Makrozyclen zur behandlung von krebserkrankungen
ATE324887T1 (de)	2006-06-15	Citalopram zur behandlung von bluthochdruck
NO20051879L (no)	2005-04-18	Anvendelse av proteintyrosinfosfataseinhibitorer til forhindring og/eller behandling av kreft
SE0301798D0 (sv)	2003-06-19	New use IV